These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26717007)

  • 21. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
    Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
    Menzies NA; Gomez GB; Bozzani F; Chatterjee S; Foster N; Baena IG; Laurence YV; Qiang S; Siroka A; Sweeney S; Verguet S; Arinaminpathy N; Azman AS; Bendavid E; Chang ST; Cohen T; Denholm JT; Dowdy DW; Eckhoff PA; Goldhaber-Fiebert JD; Handel A; Huynh GH; Lalli M; Lin HH; Mandal S; McBryde ES; Pandey S; Salomon JA; Suen SC; Sumner T; Trauer JM; Wagner BG; Whalen CC; Wu CY; Boccia D; Chadha VK; Charalambous S; Chin DP; Churchyard G; Daniels C; Dewan P; Ditiu L; Eaton JW; Grant AD; Hippner P; Hosseini M; Mametja D; Pretorius C; Pillay Y; Rade K; Sahu S; Wang L; Houben RMGJ; Kimerling ME; White RG; Vassall A
    Lancet Glob Health; 2016 Nov; 4(11):e816-e826. PubMed ID: 27720689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The costs and outcomes of paediatric tuberculosis treatment at primary healthcare clinics in Johannesburg, South Africa.
    Budgell EP; Evans D; Leuner R; Long L; Rosen S
    S Afr Med J; 2018 Apr; 108(5):423-431. PubMed ID: 29843858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
    Pooran A; Pieterson E; Davids M; Theron G; Dheda K
    PLoS One; 2013; 8(1):e54587. PubMed ID: 23349933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis.
    Cilloni L; Kranzer K; Stagg HR; Arinaminpathy N
    PLoS Med; 2020 Dec; 17(12):e1003456. PubMed ID: 33264288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness Analysis.
    Reddy KP; Horsburgh CR; Wood R; Fields NF; Girouard MP; Costantini S; Hou T; Freedberg KA; Walensky RP
    Ann Am Thorac Soc; 2020 Feb; 17(2):202-211. PubMed ID: 31689133
    [No Abstract]   [Full Text] [Related]  

  • 29. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis.
    Fitzpatrick C; Floyd K
    Pharmacoeconomics; 2012 Jan; 30(1):63-80. PubMed ID: 22070215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa.
    Floyd K; Wilkinson D; Gilks C
    BMJ; 1997 Nov; 315(7120):1407-11. PubMed ID: 9418087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active Tuberculosis Screening via a Mobile Health App in Myanmar: Incremental Cost-Effectiveness Evaluation.
    Htet KKK; Phyu AN; Zayar NN; Chongsuvivatwong V
    JMIR Form Res; 2023 Nov; 7():e51998. PubMed ID: 37948119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    Foster N; Cunnama L; McCarthy K; Ramma L; Siapka M; Sinanovic E; Churchyard G; Fielding K; Grant AD; Cleary S
    PLoS One; 2021; 16(5):e0251547. PubMed ID: 33989317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV.
    Shin H; Jo Y; Chaisson RE; Turner K; Churchyard G; Dowdy DW
    J Int AIDS Soc; 2020 Oct; 23(10):e25629. PubMed ID: 33107219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
    Masuku SD; Berhanu R; Van Rensburg C; Ndjeka N; Rosen S; Long L; Evans D; Nichols BE
    Int J Tuberc Lung Dis; 2020 Apr; 24(4):376-382. PubMed ID: 32317060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.
    Gupta S; Abimbola T; Date A; Suthar AB; Bennett R; Sangrujee N; Granich R
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1159-65. PubMed ID: 25216828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
    de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
    Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.